Fusion Scans
Back

SMMT

NASDAQ
Summit Therapeutics, Inc. · Healthcare · Biotechnology
Loading quote…

Highlights

Market Cap
$13.09B
PE Ratio
EV to Ebitda
Earnings Yield
-6.73%
Revenue (TTM)
$0.00M
Net Income (TTM)
$-1.08B
Revenue (Annual YoY Growth)
Revenue (Quarterly YoY Growth)
Profit Margin
Return on Equity
-292.79%
Debt to Equity Ratio
0.0317
Dividend Yield
0.00%

All fundamentals

Core11 fields
Market Cap$13.09B
Revenue TTM$0.00M
Shares Outstanding775.4M
Float82981124
Float Short25.00%
Days To Cover9.5670387268
Short Interest33640960.0
Insider Ownership84.11%
Institutional Ownership17.19%
Relative Strength24.3
GARP3612
Growth Estimates12 fields
Operating Revenue Growth (Annual)-1
Operating Revenue Growth (Quarterly YoY)-1
3-Year Revenue Growth-100.00%
5-Year Revenue Growth-100.00%
EPS Growth (Annual)-368.80%
EPS Growth (Quarterly YoY)-244.58%
3-Year EPS Growth Rate0.00%
5-Year EPS Growth Rate0.00%
EBITDA Growth (Annual)-418.09%
EBITDA Growth (Quarterly YoY)-241.88%
CFO Growth (Annual)-127.25%
CFO Growth (Quarterly YoY)-109.04%
Operations11 fields
Revenue TTM$0.00M
R&D Expenses TTM$537.7M
Operating Expenses TTM$1.09B
Net Income TTM$-1.08B
EPS TTM-1.4448
EPS (Quarterly)-0.286
EBITDA TTM$-1.09B
CFO TTM$-325.9M
Capital Expenditures$0.66M
FCF TTM$-326.5M
Fundamental Score4
Efficiency4 fields
ROE-292.79%
ROA-250.33%
ROIC-285.73%
CROCI-86.42%
Valuation11 fields
P/S Forward2092.8448
PEG-0.0402
EV/EBITDA Forward-23.5881
EV/Revenues Forward2005.6981
EV/CFO-39.4892
EV/FCF (TTM)-48.8361
Price To Book25.2551
Price to Tangible Book1.9218
Earnings Yield-6.73%
FCF Yield-2.04%
Dividend Yield0.00%
Relative to Industry3 fields
Relative P/B5.6588
Relative Dividend Yield0
Relative Debt to Equity0.0928
Liquidity14 fields
Cash Per Share0.9205
Current Ratio9.8688
Cash & ST Assets$713.8M
Total Debt$17.5M
Goodwill & Intangibles$2.0M
Total Assets$751.2M
Total Liabilities$92.3M
Shareholders Equity$658.9M
Debt to Equity0.0317
Debt to Assets2.78%
Interest Expense$0.00M
CFO to Debt (TTM)-35.7793
Debt to EBITDA (TTM)-0.0083
Goodwill % of Assets0.27%
Yields4 fields
Dividend Yield0.00%
Earnings Yield-6.73%
Buyback Yield-3.74%
Shareholder Yield-4.58%
Options Flow8 fields
Call Volume2866
Put Volume5034
Put/Call Ratio1.7564549895324495
Call $ Volume589874
Put $ Volume968484
Put/Call $ Ratio1.6418489372306628
Call OI116314
Put OI52607

News AI summary

Past 90 days of news, summarised by GPT

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Press release AI summary

Past 90 days of press releases, summarised by GPT

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Income statement AI analysis

Recent quarterly income statements with margin trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Balance sheet AI analysis

Recent quarterly balance sheets with leverage trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.

Cash flow AI analysis

Recent quarterly cash flow statements with FCF trends

Upgrade to use
Click Generate to run a GPT analysis. Cached for 24h once generated.